These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8161352)

  • 1. sigma recognition sites in brain and peripheral tissues. Characterization and effects of cytochrome P450 inhibitors.
    DeHaven-Hudkins DL; Lanyon LF; Ford-Rice FY; Ator MA
    Biochem Pharmacol; 1994 Mar; 47(7):1231-9. PubMed ID: 8161352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of cytochrome P-450 induction on ligand binding to sigma receptors.
    Basile AS; Paul IA; de Costa B
    Eur J Pharmacol; 1992 Sep; 227(1):95-8. PubMed ID: 1426026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H](+)-pentazocine binding to rat brain sigma 1 receptors.
    Cagnotto A; Bastone A; Mennini T
    Eur J Pharmacol; 1994 Jan; 266(2):131-8. PubMed ID: 8157067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
    Nguyen VH; Kassiou M; Johnston GA; Christie MJ
    Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY
    Eur J Pharmacol; 1992 Dec; 227(4):371-8. PubMed ID: 1359973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies in characterization of sigma sites in the mouse central nervous system.
    Kovács KJ; Larson AA
    Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
    Brent PJ
    Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]1,3-di(2-tolyl) guanidine binds to a sigma 2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes.
    DeHaven-Hudkins DL; Daubert JD; Sawutz DG; Tiberio L; Baine Y
    Immunopharmacology; 1996 Oct; 35(1):27-39. PubMed ID: 8913792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
    Hellewell SB; Bowen WD
    Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple [3H]DTG binding sites in guinea pig cerebellum: evidence for the presence of non-specific binding.
    Basile AS; DeCosta B; Paul IA
    Eur J Pharmacol; 1994 Feb; 252(2):139-46. PubMed ID: 8157054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
    Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC
    Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands.
    Matsumoto RR; Bowen WD; de Costa BR; Houk JC
    Brain Res Bull; 1999 Mar; 48(5):497-508. PubMed ID: 10372510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorphan and sigma ligands to guinea pig brain.
    Klein M; Canoll PD; Musacchio JM
    Life Sci; 1991; 48(6):543-50. PubMed ID: 1846936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450.
    Ross SB
    Pharmacol Toxicol; 1991 Apr; 68(4):293-301. PubMed ID: 1650944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain.
    Chaki S; Tanaka M; Muramatsu M; Otomo S
    Eur J Pharmacol; 1994 Jan; 251(1):R1-2. PubMed ID: 8137864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study.
    Walker JM; Bowen WD; Goldstein SR; Roberts AH; Patrick SL; Hohmann AG; DeCosta B
    Brain Res; 1992 May; 581(1):33-8. PubMed ID: 1323368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
    Codd EE; Shank RP
    Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions.
    Torrence-Campbell C; Bowen WD
    Eur J Pharmacol; 1996 May; 304(1-3):201-10. PubMed ID: 8813603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC
    Life Sci; 1992; 50(9):PL65-70. PubMed ID: 1346920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.